Cuál es el precio por Entia Biosciences, Inc. (ERGO)

Precio por Entia Biosciences, Inc. (ERGO) es de$0.0002

Cuál es la capitalización de mercado por Entia Biosciences, Inc. (ERGO)

Capitalización de mercado por Entia Biosciences, Inc. (ERGO) es $6.73K

Entia Biosciences, Inc. (ERGO) Ratio P/E

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.

Año	Ratio P/E	Cambiar
Not enough data for the provided dates.

Año

Ratio P/E

Cambiar

Not enough data for the provided dates.

Empresa	P/E Ratio	Diferencia del P/E Ratio	País
Royalty Pharma plc RPRX.US	23.71	-	US
Swedish Orphan Biovitrum AB SOBI.ST	-	-	SE
Ipsen S.A. IPN.PA	-	-	FR
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	-	-	IT
Corcept Therapeutics Incorporated CORT.US	220.17	-	US

Empresa

P/E Ratio

Diferencia del P/E Ratio

País